Today

Agents

Chat

Arena

Discover

More

App

Amgen price objective raised to $328 from $317

AMGN•2026-10-12

BofA Global Research raised its price objective for Amgen to $328 from $317.

Related News

I

Interactive Brokers Group: Deutsche Bank initiates coverage with buy rating and $102 target price

IBKR•2026-10-12

Affiliated Managers Group target price raised to $523 from $512

AMG•2026-10-12

Chord Energy Corporation: Truist Securities raises target price to $195 from $180

CHRD•2026-10-12

First Tracks Biotherapeutics announces positive top-line ANB033 results in celiac disease study

TRAX•2026-10-12

Microsoft: Deutsche Bank raises target price to $600 from $550

MSFT•2026-10-12

Amgen price objective raised to $328 from $317 - AMGN News | Rallies